SHARE

Over €500M raised by EIT Health Gold Track alumni

13th March 2024

Over the last four years, EIT Health’s Gold Track Programme, run in partnership with Advise Connect Inspire LLC, has paired top-flight European start-ups with world-class life science advisors to accelerate their growth, unlocking ambitious business plans and investment opportunities within short time frames. Participating start-ups have gone on to collectively raise over 500 million euros in funds.

Since 2019, the programme has supported 45 companies across 15 European countries with customised strategic advice, all of which had massively scalable technologies across 19 different therapeutic areas including Biotech, Medtech, and Digital Health. In terms of investment, many alumni companies have secured investment from funding rounds including: Ochre Bio, a biotech startup developing RNA therapies for liver disease, who closed a €30M Series A funding round; AI drug discovery company Turbine raised €25.5M in their series A funding round; and pioneering gene-editing company Eligo Bioscience also secured a $30 million investment.

Additionally, Gold Track cultivated three successful exits: PhagoMed was acquired by BioNTech, Rahko merged with Odyssey Therapeutics, and OmicEra was acquired by Exact Sciences.

Alexander Belcredi and Lorenzo Corsini, co-CEOs of PhagoMed, said: “Gold Track was really transformative for PhagoMed. The mentorship and advice were excellent and contributed to our successful exit to BioNTech. Participating in Gold Track is a game-changer for young companies to fast-track their development.”

The key element of the Gold Track programme was the exclusive access to the Expert Council, a world-class pool of executives, investors, and experts in their respective fields, all of whom are passionate about contributing to strengthening the European healthcare system. Either directly or indirectly, the Expert Council members were central to the success of the Gold Track companies. In addition to the Expert Council members, the Strategic Leads, Programme Directors, mentors and experts who participated in Gold Track were all instrumental to the success of the companies.

EIT Health incubates and accelerates healthcare start-ups and SMEs across Europe through our unique portfolio of business creation programmes. By activating our vast network of world-leading Partners, we connect entrepreneurial businesses to the knowledge and resources they need to attract investment and grow. Our business creation programmes enable start-ups and SMEs to bring life-changing innovations to market faster, create new jobs and boost the European health economy. Explore our portfolio of supported start-ups to learn more about the businesses we help to grow.

EIT Health-supported ABLE Human Motion receives CE mark

EIT Health-supported ABLE Human Motion receives CE mark

Learn how EIT Health has supported their journey.

Find out more

EDIT-B launches the first blood test that can differentiate bipolar disorder from depression in France

EDIT-B launches the first blood test that can differentiate bipolar disorder from depression in France

Hear from those diagnosed with Bipolar Disorder

Find out more

EIT Health appoints four new Supervisory Board members

EIT Health appoints four new Supervisory Board members

Meet our new board members.

Find out more